Company / Capital Returned to Shareholders per Share
Dexcom Capital Returned to Shareholders per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$1.30
FY2025
5-year range
$0.00 / $1.92
FY2021-FY2025
Trend
-32.3%
vs FY2024
Sector context
#56 of 108
Health Care
What the data says
At $1.30, Dexcom's capital returned to shareholders per share ranks #56 of 108 in the Health Care sector. Declined from $1.79 to $1.30 over the past 2 years.
Based on SEC 10-K filings.
1.30 in FY2025.
Declined from $1.79 to $1.30 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#56 of 108 in Health CareTop 52% of 108This company $1.30 Sector average $4.94
▼
-73.7% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share decreased 32.3% year-over-year.
- Ranks #56 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2024.
- Lowest capital returned to shareholders per share in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.30 | -32.3% |
| FY2024 | $1.92 | +7.4% |
| FY2023 | $1.79 | - |
| FY2022 | $0.00 | - |
| FY2021 | $0.00 | - |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | -100.0% |
| FY2018 | $1.15 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026